S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Apexigen, Inc. stock logo
APGN
Apexigen
$0.39
$0.39
$0.33
$8.28
$9.57M3.6967,731 shsN/A
Direxion Moonshot Innovators ETF stock logo
MOON
Direxion Moonshot Innovators ETF
$8.87
-1.4%
$10.46
$8.57
$14.95
$20.67M1.1418,382 shs11,626 shs
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Apexigen, Inc. stock logo
APGN
Apexigen
0.00%0.00%0.00%0.00%-22.81%
Direxion Moonshot Innovators ETF stock logo
MOON
Direxion Moonshot Innovators ETF
-0.11%-10.95%-13.34%-5.84%-18.50%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Apexigen, Inc. stock logo
APGN
Apexigen
N/AN/AN/AN/AN/AN/AN/AN/A
Direxion Moonshot Innovators ETF stock logo
MOON
Direxion Moonshot Innovators ETF
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Apexigen, Inc. stock logo
APGN
Apexigen
N/AN/AN/AN/A
Direxion Moonshot Innovators ETF stock logo
MOON
Direxion Moonshot Innovators ETF
0.00
N/A$18.07103.74% Upside

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Apexigen, Inc. stock logo
APGN
Apexigen
N/AN/AN/AN/A($0.09) per shareN/A
Direxion Moonshot Innovators ETF stock logo
MOON
Direxion Moonshot Innovators ETF
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Apexigen, Inc. stock logo
APGN
Apexigen
-$32.07MN/A0.00N/AN/A-614.82%-133.30%N/A
Direxion Moonshot Innovators ETF stock logo
MOON
Direxion Moonshot Innovators ETF
N/AN/A0.00N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Apexigen, Inc. stock logo
APGN
Apexigen
N/AN/AN/AN/AN/A
Direxion Moonshot Innovators ETF stock logo
MOON
Direxion Moonshot Innovators ETF
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Apexigen, Inc. stock logo
APGN
Apexigen
N/A
0.82
0.82
Direxion Moonshot Innovators ETF stock logo
MOON
Direxion Moonshot Innovators ETF
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Apexigen, Inc. stock logo
APGN
Apexigen
13.65%
Direxion Moonshot Innovators ETF stock logo
MOON
Direxion Moonshot Innovators ETF
N/A

Insider Ownership

CompanyInsider Ownership
Apexigen, Inc. stock logo
APGN
Apexigen
19.20%
Direxion Moonshot Innovators ETF stock logo
MOON
Direxion Moonshot Innovators ETF
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Apexigen, Inc. stock logo
APGN
Apexigen
1124.86 million20.09 millionNot Optionable
Direxion Moonshot Innovators ETF stock logo
MOON
Direxion Moonshot Innovators ETF
N/A2.33 millionN/ANot Optionable

BOO, APGN, MOON, and AO Headlines

SourceHeadline
Direxion Moonshot Innovators ETF declares quarterly distribution of $0.0347Direxion Moonshot Innovators ETF declares quarterly distribution of $0.0347
msn.com - March 21 at 3:54 PM
5 Best ETF Areas of Last Week5 Best ETF Areas of Last Week
zacks.com - March 5 at 9:46 AM
FDTX: Richly Priced Outperforming Growth StoryFDTX: Richly Priced Outperforming Growth Story
seekingalpha.com - February 20 at 6:49 AM
Direxion Moonshot Innovators ETF declares $0.0156 dividendDirexion Moonshot Innovators ETF declares $0.0156 dividend
msn.com - December 27 at 3:58 PM
Direxion Moonshot Innovators ETF declares quarterly distribution of $0.0156Direxion Moonshot Innovators ETF declares quarterly distribution of $0.0156
msn.com - December 21 at 5:44 PM
Harbor ETF Trust Harbor Disruptive Innovation ETF (ARCA:INNO) Dividends: History, Yield and DatesHarbor ETF Trust Harbor Disruptive Innovation ETF (ARCA:INNO) Dividends: History, Yield and Dates
benzinga.com - December 5 at 11:25 PM
Morningstar warns against AI-focused ETFs in new reportMorningstar warns against AI-focused ETFs in new report
pionline.com - June 21 at 5:54 PM
Direxion Moonshot Innovators ETF (MOON)Direxion Moonshot Innovators ETF (MOON)
finance.yahoo.com - March 7 at 11:14 AM
ASX reveals best and worst ETFs: What can we learn for 2023?ASX reveals best and worst ETFs: What can we learn for 2023?
finder.com.au - January 17 at 11:08 PM
Direxion Daily Retail Bull 3X Shares declares distribution of $0.0178Direxion Daily Retail Bull 3X Shares declares distribution of $0.0178
msn.com - December 21 at 2:31 PM
DIREXION MOONSHOT INNOVATORS ET (^MOON-TC)DIREXION MOONSHOT INNOVATORS ET (^MOON-TC)
finance.yahoo.com - October 17 at 2:14 AM
Is MicroVision Stock Overvalued Or Undervalued? Its Significantly OverpricedIs MicroVision Stock Overvalued Or Undervalued? It's Significantly Overpriced
seekingalpha.com - August 19 at 1:48 PM
InnovationRx: Stretching Monkeypox Vaccine Doses; Plus, Omicron Subvariant BoostersInnovationRx: Stretching Monkeypox Vaccine Doses; Plus, Omicron Subvariant Boosters
msn.com - August 10 at 7:27 PM
Could a Sustained Tech ETF Rally Be in the Cards?Could a Sustained Tech ETF Rally Be in the Cards?
uk.finance.yahoo.com - July 17 at 12:14 AM
3 Ways To Trade SaaS Platform Asana As Tech Stocks Struggle3 Ways To Trade SaaS Platform Asana As Tech Stocks Struggle
uk.investing.com - June 10 at 8:43 AM
Cathie Wood Sees Huge Inventories as Evidence Inflation Will EbbCathie Wood Sees Huge Inventories as Evidence Inflation Will Ebb
investing.com - June 10 at 8:43 AM
Investors in Moonpig Group (LON:MOON) have unfortunately lost 48% over the last yearInvestors in Moonpig Group (LON:MOON) have unfortunately lost 48% over the last year
finance.yahoo.com - March 24 at 6:59 AM
Granite Creek Copper Identifies New Targets at Carmacks Copper-Gold Project Through Deployment of GoldSpot Discoveries Artificial Intelligence TechnologyGranite Creek Copper Identifies New Targets at Carmacks Copper-Gold Project Through Deployment of GoldSpot Discoveries' Artificial Intelligence Technology
finance.yahoo.com - February 14 at 11:04 AM
Leveraged ETF: How to Use & Whats Hot Now?Leveraged ETF: How to Use & What's Hot Now?
nasdaq.com - February 3 at 9:23 PM
Direxion Moonshot Innovators ETFDirexion Moonshot Innovators ETF
realmoney.thestreet.com - January 23 at 12:00 AM
Xunlei Limited (NASDAQ: XNET): Can The Stock Still Lose Despite An -30.45% YTD Loss?Xunlei Limited (NASDAQ: XNET): Can The Stock Still Lose Despite An -30.45% YTD Loss?
marketingsentinel.com - January 4 at 12:53 AM
After A -30.16% Fall This Year Is Xunlei Limited (NASDAQ:XNET) A Better Buy Than Others?After A -30.16% Fall This Year Is Xunlei Limited (NASDAQ:XNET) A Better Buy Than Others?
marketingsentinel.com - December 25 at 2:03 PM
Is Xunlei Limited (NASDAQ: XNET) Worth Much? What Should Investors Do?Is Xunlei Limited (NASDAQ: XNET) Worth Much? What Should Investors Do?
marketingsentinel.com - December 17 at 12:06 PM
Let’s Talk About How Xunlei Limited (NASDAQ: XNET) Stock Is Doing.Let’s Talk About How Xunlei Limited (NASDAQ: XNET) Stock Is Doing.
marketingsentinel.com - December 14 at 12:27 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Apexigen logo

Apexigen

NASDAQ:APGN
Apexigen, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and ovarian cancers in combination with immunotherapy, chemotherapy, radiation therapy, and cancer vaccines; and APX601, a humanized antagonist antibody that is in Phase I/II clinical trial for the treatment of multiple tumor indications, as well as APX801, an NK cell engager to activate natural killer cells to killing of tumor cells. Apexigen, Inc. was founded in 2010 and is headquartered in San Carlos, California.
Direxion Moonshot Innovators ETF logo

Direxion Moonshot Innovators ETF

NYSEARCA:MOON
The Direxion Moonshot Innovators ETF (MOON) is an exchange-traded fund that is based on the S&P Kensho Moonshots index. The fund tracks a tier-weighted index that selects US-listed companies seeking innovative technologies. MOON was launched on Nov 12, 2020 and is managed by Direxion.